Publikationen in Zusammenarbeit mit Forschern von Instituto de Salud Carlos III (6)

2022

  1. First computational design using lambda-superstrings and in vivo validation of SARS-CoV-2 vaccine

    Scientific Reports, Vol. 12, Núm. 1

2017

  1. Monocytes phenotype and cytokine production in human immunodeficiency virus-1 infected patients receiving a modified vaccinia ankara-based HIV-1 vaccine: Relationship to CD300 molecules expression

    Frontiers in Immunology, Vol. 8, Núm. JUL

2015

  1. Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 6, pp. 1833-1842

2012

  1. Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745

1997

  1. Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: Comparative analysis of carbohydrate structures and the antigen presenting cell

    Cellular Immunology, Vol. 176, Núm. 1, pp. 1-13

  2. The consequences of the intracellular retention of pathogen-derived T- cell-independent antigens on protein presentation to T cells

    Clinical Immunology and Immunopathology, Vol. 85, Núm. 1, pp. 1-15